Warp speed RNA vaccine development and manufacturing in the Covid Age: How can we mass produce high-quality vaccines faster and cheaper? | Advanced instruments
We are open and continue to provide essential lab supplies during the COVID-19 pandemic. Answers to your FAQ’s can be found here. Read More

Warp speed RNA vaccine development and manufacturing in the Covid Age: How can we mass produce high-quality vaccines faster and cheaper?

Webinar part of the Oxford Global Formulation and Delivery Series Virtual Workshop.

Developments in MAb and Cell and Gene therapies and the need for “warp speed” vaccine development all bring challenges to the formulation of drug products. This is especially the case in a more heavily regulated biopharmaceutical environment. This workshop will dive into how osmolality measurements aid formulation development strategies to ensure consistent and painless injection whether of rapidly developed vaccines, biologic drugs or cryo-preserved cell therapies.

Presented by: Dr. Zoltan Kis, Biotechnologist and Bioprocess Engineer, Imperial College London